Neoadjuvant sintilimab and anlotinib combined with chemotherapy for resectable NSCLC: A prospective, single arm, multicenter study

Authors
Category Primary study
JournalJournal of Thoracic Oncology
Year 2023
This article has no abstract
Epistemonikos ID: d314132bbb4438ce80cfa034ea5a82fbe4dc15ea
First added on: Feb 15, 2025